Clinical trial
Efalizumab for Eczema
NCT00146003 · University of Medicine and Dentistry of New Jersey, Other · Completed
Key facts
| NCT number | NCT00146003 |
|---|---|
| Title | Efalizumab for Eczema |
| Official title | Investigator-Initiated Trial of Efalizumab for Atopic Dermatitis: A Proof of Concept Study in Adults |
| Lead sponsor | University of Medicine and Dentistry of New Jersey, Other |
| Collaborators | Genentech, Inc. Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Dermatitis, Atopic |
| Intervention type | Drug |
| Interventions | Efalizumab treatment |
| Enrollment | 10 |
| Start date | Mar 1, 2005 |
| Completion | Dec 1, 2007 |
| First posted | Sep 5, 2005 |
| Last update posted | Aug 7, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: